Form 8-K - Current report:
SEC Accession No. 0001140361-26-006721
Filing Date
2026-02-25
Accepted
2026-02-25 07:30:36
Documents
17
Period of Report
2026-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20066378_8k.htm   iXBRL 8-K 35280
2 EXHIBIT 99.1 ef20066378_ex99-1.htm EX-99.1 228631
7 image00001.jpg GRAPHIC 3921
8 image00002.jpg GRAPHIC 3290
9 image00003.jpg GRAPHIC 3433
  Complete submission text file 0001140361-26-006721.txt   473291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20260225.xsd EX-101.SCH 4663
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imcr-20260225_def.xml EX-101.DEF 17874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20260225_lab.xml EX-101.LAB 27191
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20260225_pre.xml EX-101.PRE 20059
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20066378_8k_htm.xml XML 6654
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 26674209
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)